Founders Fund VII Management’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,773,530	Closed	-$11.2M	–	2
2024 Q2	$11.2M	Hold	3,773,530	–	–	86.9%	1
2024 Q1	$17.1M	Hold	3,773,530	–	–	88.05%	1
2023 Q4	$21.5M	Hold	3,773,530	–	–	89.83%	1
2023 Q3	$17.4M	Hold	3,773,530	–	–	89.37%	1
2023 Q2	$24.4M	Hold	3,773,530	–	–	91.35%	1
2023 Q1	$28.5M	Hold	3,773,530	–	–	91.13%	1
2022 Q4	$38.2M	Hold	3,773,530	–	–	94.47%	1
2022 Q3	$37.3M	Hold	3,773,530	–	–	92.58%	1
2022 Q2	$40.2M	Hold	3,773,530	–	–	93.02%	1
2022 Q1	$36.8M	Hold	3,773,530	–	–	91.1%	1
2021 Q4	$54M	Hold	3,773,530	–	–	89.75%	1
2021 Q3	$75.6M	Hold	3,773,530	–	–	86.1%	1
2021 Q2	$83M	Hold	3,773,530	–	–	79.6%	1
2021 Q1	$128M	Hold	3,773,530	–	–	86.19%	1
2020 Q4	$152M	Buy	+3,773,530	New	+$173M	85.11%	1